LifeArc

Liverpool School of Tropical Medicine (LSTM) and LifeArc are partnering to launch a new Translational Development Fund to help tackle infectious diseases. LifeArc will invest £2.7 ($3.4) million into the fund, which will support the progression of new technologies and treatments for emerging viral threats and neglected tropical diseases. The fund will be available to […]

A new project by researchers in Edinburgh aims to identify combinations of existing drugs that could be used together to treat motor neurone disease (MND). Led by Prof Siddharthan Chandran, the £3.3 million project is funded by the medical research charity LifeArc, as part of an ongoing partnership between the charity and the UK DRI. […]

Not-for-profit medical research organisation LifeArc and techbio company PrecisionLife have agreed a strategic R&D collaboration to accelerate the discovery of targeted treatments for motor neurone disease (MND). MND is also known as amyotrophic lateral sclerosis (ALS) and Lou Gehrig’s disease. The collaboration will accelerate findings by PrecisionLife working with the Motor Neurone Disease Association and […]

UK-based Cystic fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) has announced a £3 million ($3.6 million) Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF. Funded by UK medical research charity LifeArc, the programme will support approximately five collaborative projects that aim to rapidly identify new […]

A free online toolkit has been launched to help researchers navigate the opportunities and challenges of repurposing medicines for different indications. The toolkit was created by medical research charity LifeArc and the Medical Research Council (MRC). “Having learned the challenges of repurposing firsthand, I think this toolkit is enormously practical and valuable,” commented Professor Patrick […]